Anti-tumor activity of CD3 − CD56 + NK cells against K562 targets was also significantly inhibited by exosomes isolated from plasma of HNC patients; while no suppression was observed with exosomes isolated either from healthy donors or those patients with no evident disease [23]. This evidence concerns the gene NCAM1 and neoplasm.